Cost-effectiveness of Hydrocortisone Injection, Symbicort Inhaler and Prednisolone Tablets Used in Treatment of Asthma in Alshaab Teaching Hospital Khartoum, Sudan
1, 1★, 1, 2★ Corresponding author
- 1Department of Pharmacy Practice, Faculty of Pharmacy, International University of Africa, Khartoum, SUDAN.
- 2Department of Surgery, Alzaeim Alazhari University, Khartoum North, SUDAN.
CORRESPONDENCE
Mousnad Mohamed Awad
Department of Pharmacy Practice, Faculty of Pharmacy, International University of Africa, Khartoum, SUDAN.
Received: 24-10-2022; Revised: 30-01-2023; Accepted: 11-02-2023.
Volume 15, Issue 2 · pp. 360-367 · 2023 · DOI: 10.5530/jyp.2023.15.48
ABSTRACT
Background: Asthma is a chronic disease and one of the most familiar long-term respiratory diseases affecting millions of adults worldwide. High utilisation of healthcare resources in treating asthma and limited resources allocated to the disease has imposed the use of Pharmaco-economics evaluation methods such as cost-effectiveness analysis in healthcare decision-making. Hence, the present study is planned to evaluate the cost-effectiveness of corticosteroid preparations used in treating asthmatic patients at Alshaab Teaching Hospital (ASH) Khartoum, Khartoum State, Sudan.Materials and Methods: A hospital-based cross-sectional design, whereby the cost and outcome of corticosteroid preparations were collected together. One hundred and thirty-nine adult asthmatic patients were systematically selected as the sample size. The data were collected using EQ-5D-3L Arabic version questionnaire and data collection forms and analysed using Statistical Package for Social Sciences (IBM) version 24.0.Results: In this study, out of 139 patients, the majority of them (58%) were females, fell within the 16-40 age group category (38%) and were married (82%). Our findings showed that the Symbicort inhaler was the most expensive preparation with an Average Cost-Effectiveness Ratio (ACER) of 3,283.10 SDG ($4901) per treatment. Prednisolone tablet was the least expensive, with an ACER of 643.40 SDG ($ 96) per treatment, the most reasonable alternative concerning effectiveness, and the most efficient preparation concerning effectiveness-adjusted costs.Conclusion: This study concluded that the prevalence of asthma and utilisation of pharmaceutical products and services among adult asthmatic patients in ASH was higher in females (58%) and those in the 16-40 age group. The Symbicort inhaler was the most expensive preparation, and the Prednisolone tablet was the least expensive and most cost-effective of the three preparations evaluated in ASH.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Abdulrahman, M., Awad, M. M., Ahmad, A. N. M., & Sayed, A. E. (2023). Cost-effectiveness of Hydrocortisone Injection, Symbicort Inhaler and Prednisolone Tablets Used in Treatment of Asthma in Alshaab Teaching Hospital Khartoum, Sudan. Journal of Young Pharmacists, 15(2), 360-367. https://doi.org/10.5530/jyp.2023.15.48
Copyright and licence
© 2023 Author(s)
This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. CC BY-NC-SA 4.0